Innovative Inhibitors against Viral Targets
A special issue of Viruses (ISSN 1999-4915). This special issue belongs to the section "Viral Immunology, Vaccines, and Antivirals".
Deadline for manuscript submissions: closed (31 July 2023) | Viewed by 13459
Special Issue Editors
Interests: antivirals; retroviruses; filoviruses; host–pathogen interactions
Interests: host-pathogen interactions; alphaviruses; filoviruses; innate immunity; host-based antivirals
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Viruses are pathogens prone to rapid host adaptation and to the selection of drug-resistant variants. The current COVID-19 pandemic reminded us of the urgent need for antiviral drugs to face present and future outbreaks. Additionally, constant effort is needed to identify new viral inhibitors for both acute and persistent viral infections. Viral-encoded proteins that cannot be complemented by host functions are validated targets to be exploited, especially if they exhibit a high level of conservation upon selective pressure.
This Special Issue of the journal Viruses on “Innovative Inhibitors against Viral Targets” is focused on the solutions being explored to block viral-encoded targets. We welcome submissions including but not limited to:
- Modulation of the antiviral innate immune response—a target for the development of novel pan-viral therapeutic strategies;
- Inhibitors of viral enzymes and functions;
- Natural products (derivatives) as inhibitors.
Dr. Angela Corona
Dr. St Patrick Reid
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- viral proteins
- virus replication
- antivirals
- viral targets
- molecular virology
- target-based drug design
- host-pathogen interaction